Ansaldi F - Search Results

1

Vaccine-preventable infections in Systemic Lupus Erythematosus.

Murdaca G, Orsi A, Spanò F, Faccio V, Puppo F, Durando P, Icardi G, Ansaldi F. Murdaca G, et al. Among authors: ansaldi f. Hum Vaccin Immunother. 2016 Mar 3;12(3):632-43. doi: 10.1080/21645515.2015.1107685. Hum Vaccin Immunother. 2016. PMID: 26750996 Free PMC article. Review.

2

Evaluation of a new hepatitis C virus sequencing assay as a routine method for genotyping.

Ansaldi F, Torre F, Bruzzone BM, Picciotto A, Crovari P, Icardi G. Ansaldi F, et al. J Med Virol. 2001 Jan;63(1):17-21. J Med Virol. 2001. PMID: 11130882

3

Identification of key mutations in HIV reverse transcriptase gene can influence the clinical outcome of HAART.

Setti M, Bruzzone B, Ansaldi F, Borrelli P, Indiveri F, Icardi G. Setti M, et al. Among authors: ansaldi f. J Med Virol. 2001 Jul;64(3):199-206. doi: 10.1002/jmv.1037. J Med Virol. 2001. PMID: 11424105

4

Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen.

Icardi G, Ansaldi F, Bruzzone BM, Durando P, Lee S, de Luigi C, Crovari P. Icardi G, et al. Among authors: ansaldi f. J Clin Microbiol. 2001 Sep;39(9):3110-4. doi: 10.1128/JCM.39.9.3110-3114.2001. J Clin Microbiol. 2001. PMID: 11526137 Free PMC article.

5

Antiviral activity of amantadine in elderly patients with chronic hepatitis C.

Torre F, Campo N, Giusto R, Ansaldi F, Icardi GC, Picciotto A. Torre F, et al. Among authors: ansaldi f. Gerontology. 2001 Nov-Dec;47(6):330-3. doi: 10.1159/000052823. Gerontology. 2001. PMID: 11721147 Clinical Trial.

6

Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.

Testino G, Ansaldi F, Andorno E, Ravetti GL, Ferro C, De Iaco F, Icardi G, Valente U. Testino G, et al. Among authors: ansaldi f. Hepatogastroenterology. 2002 Nov-Dec;49(48):1636-8. Hepatogastroenterology. 2002. PMID: 12397752

7

Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients.

Giannini E, Ceppa P, Botta F, Fasoli A, Romagnoli P, Ansaldi F, Durando P, Risso D, Lantieri PB, Icardi GC, Testa R. Giannini E, et al. Among authors: ansaldi f. Liver Int. 2003 Feb;23(1):12-8. doi: 10.1034/j.1600-0676.2003.01742.x. Liver Int. 2003. PMID: 12640722

8

A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects?

Icardi G, Bruzzone B, Gota F, Torre F, Giannini E, Massone L, Li Bassi A, Lai PL, Picciotto A, Ansaldi F. Icardi G, et al. Among authors: ansaldi f. Ann Ig. 2003 Nov-Dec;15(6):863-70. Ann Ig. 2003. PMID: 15049543

9

Antigenic characterisation of influenza B virus with a new microneutralisation assay: comparison to haemagglutination and sequence analysis.

Ansaldi F, Bacilieri S, Amicizia D, Valle L, Banfi F, Durando P, Sticchi L, Gasparini R, Icardi G, Crovari P. Ansaldi F, et al. J Med Virol. 2004 Sep;74(1):141-6. doi: 10.1002/jmv.20157. J Med Virol. 2004. PMID: 15258980

10

Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy.

Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, Icardi G. Ansaldi F, et al. J Med Virol. 2005 Jul;76(3):327-32. doi: 10.1002/jmv.20376. J Med Virol. 2005. PMID: 15902713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters